Coastal Infusion Administers Inflectra^®

Inflectra (infliximab-dyyb) is used to treat rheumatoid arthritis (RA) and psoriatic arthritis, Crohn's disease, and ulcerative colitis (UC). Inflectra also treats plaque psoriasis and ankylosing spondylitis

Inflectra attaches to a chemical messenger in the body called tumor necrosis factor alpha (TNF-alpha). This messenger causes inflammation and is found at elevated levels in patients with the diseases that Inflectra is used to treat. By blocking TNF-alpha, Inflectra reduces inflammation and other symptoms of diseases.

What It Treats

• Crohn's disease
• Ulcerative colitis (UC)
• Rheumatoid arthritis (RA)
• Psoriatic arthritis
• Plaque psoriasis
• Ankylosing spondylitis

Prescribed By

Inflectra is most often prescribed by Gastroenterologists, Rheumatologists, and Dermatologists.

How it's Administered

Inflectra is administered by intravenous infusion. Inflectra infusions take about two hours.

Frequency

Inflectra is administered every eight weeks (every 6 weeks for ankylosing spondylitis) after an induction regimen that includes three doses over six weeks.

Related Drugs

Avsola, Remicade, Renflexis

Additional Resources

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies